Skip to main content

Smith & Nephew Snats ADR(SNN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low29.60
Day High29.94
Open:29.82
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Smith & Nephew Sets Sterling Rate for 2025 Final Dividend Ahead of May 27 Payout
Smith+Nephew launches up to $250 million share buyback first tranche
Smith & Nephew (SN) Receives a Buy from Kepler Capital
Smith & Nephew (SN) Gets a Hold from Barclays
Smith & Nephew AGM Approves All Resolutions Amid Pushback on Pay Plans
Smith & Nephew posts solid Q1 2026 growth and launches $500m buyback
Smith & Nephew Holds Guidance, Unveils $500 Million Buyback on Solid Q1 2026 Trading
Berenberg Bank Reaffirms Their Hold Rating on Smith & Nephew Snats (SNN)
Smith+Nephew drives progress in chronic wound care with ALLEVYNâ„¢COMPLETE CARE Dressing and RENASYSâ„¢ EDGE tNPWT set to launch at EWMA 2026
Barclays Sticks to Their Hold Rating for Smith & Nephew (SN)
Smith+Nephew to Showcase Growth-Driving Surgical Innovations at June Investor Event
Smith+Nephew Sets 6 May Date for Q1 2026 Trading Update
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years
Smith & Nephew Grants Nil‑Cost RISE Share Plan Awards to Senior Leadership
Smith & Nephew Discloses Board Role Expansion for Senior Independent Director Designate
Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*
Smith & Nephew Grants New Executive Share Awards and Tightens Governance Under Long-Term Incentive Plans
Smith & Nephew Updates Share Capital and Voting Rights as of 31 March 2026

Profile

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world